Nanthealth Earnings Estimate

NH
 Stock
  

USD 0.61  0.04  7.02%   

Many public companies, such as Nanthealth, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Nanthealth's earnings estimates, investors can diagnose different trends across Nanthealth's analyst sentiment over time as well as compare current estimates against different timeframes.
Nanthealth is projected to generate -0.39 in earnings per share on the 31st of December 2021. Nanthealth earnings estimates module stress-tests analyst consensus about projected Nanthealth EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Additionally, see Stocks Correlation.
  
The current Gross Profit is estimated to decrease to about 47.2 M

Nanthealth Earnings Estimation Breakdown

Calculation of earning per share of Nanthealth is based on official Zacks consensus of 1 analysts regarding Nanthealth future annual earnings. Given the historical accuracy of 73.33%, the future earnings per share of Nanthealth is estimated to be -0.39 with the lowest and highest values of -0.4 and -0.38, respectively. Please note that this consensus of annual earnings estimates for Nanthealth is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -0.55
-0.4
Lowest
Expected EPS -0.39
-0.38
Highest

Nanthealth Earnings Projection Consensus

Suppose the current estimates of Nanthealth's value are higher than the current market price of the Nanthealth stock. In this case, investors may conclude that Nanthealth is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Nanthealth's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

1

73.33%

-0.549

-0.39

Nanthealth Earnings per Share Projection vs Actual

Actual Earning per Share of Nanthealth refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Nanthealth predict the company's earnings will be in the future. The higher the earnings per share of Nanthealth, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Nanthealth Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Nanthealth, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Nanthealth should always be considered in relation to other companies to make a more educated investment decision.

Nanthealth Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Nanthealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-04
2022-06-30-0.09-0.1-0.0111 
2022-05-05
2022-03-31-0.09-0.11-0.0222 
2022-02-24
2021-12-31-0.08-0.1-0.0225 
2021-11-04
2021-09-30-0.08-0.1-0.0225 
2021-08-05
2021-06-30-0.09-0.080.0111 
2021-05-06
2021-03-31-0.07-0.09-0.0228 
2021-02-25
2020-12-31-0.08-0.060.0225 
2020-11-05
2020-09-30-0.06-0.07-0.0116 
2020-08-06
2020-06-30-0.05-0.07-0.0240 
2020-05-07
2020-03-31-0.06-0.060
2020-02-28
2019-12-31-0.05-0.040.0120 
2019-11-07
2019-09-30-0.04-0.07-0.0375 
2019-08-08
2019-06-30-0.09-0.040.0555 
2019-05-09
2019-03-31-0.1-0.10
2019-03-28
2018-12-31-0.09-0.080.0111 
2018-11-15
2018-09-30-0.12-0.10.0216 
2018-08-09
2018-06-30-0.11-0.10.01
2018-05-09
2018-03-31-0.11-0.12-0.01
2018-03-14
2017-12-31-0.14-0.070.0750 
2017-11-09
2017-09-30-0.13-0.130
2017-08-10
2017-06-30-0.15-0.18-0.0320 
2017-05-10
2017-03-31-0.19-0.24-0.0526 
2017-03-30
2016-12-31-0.19-0.180.01
2016-11-07
2016-09-30-0.2-0.180.0210 
2016-08-09
2016-06-30-0.41-0.150.2663 

About Nanthealth Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Nanthealth earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Nanthealth estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Nanthealth fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit-902.9 M-974.2 M
Earning Before Interest and Taxes EBIT-42.2 M-45.5 M
Earnings per Basic Share(2.02) (2.18) 
Earnings per Diluted Share(2.02) (2.18) 
Price to Earnings Ratio(5.70) (5.85) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-46.5 M-50.2 M
Earnings before Tax-64.3 M-69.3 M
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Nanthealth operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 326 people.

Nanthealth Investors Sentiment

The influence of Nanthealth's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Nanthealth. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Nanthealth's public news can be used to forecast risks associated with investment in Nanthealth. The trend in average sentiment can be used to explain how an investor holding Nanthealth can time the market purely based on public headlines and social activities around Nanthealth. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Nanthealth's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Nanthealth's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Nanthealth's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Nanthealth.

Nanthealth Implied Volatility

    
  0.0  
Nanthealth's implied volatility exposes the market's sentiment of Nanthealth stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nanthealth's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nanthealth stock will not fluctuate a lot when Nanthealth's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nanthealth in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nanthealth's short interest history, or implied volatility extrapolated from Nanthealth options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nanthealth using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
70.9 M
Quarterly Revenue Growth YOY
0.025
Return On Assets
-0.15
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.